ModelEdge

Xeris Pharmaceuticals Inc
0001346302
Filing Type8-K
Filing Date10/4/2021
Updated10/5/21, 10:15 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-4.1EX-4.1
EX-10.1EX-10.1